<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Trypanosoma cruzi, the etiologic agent of <z:e sem="disease" ids="C0041234" disease_type="Disease or Syndrome" abbrv="">Chagas disease</z:e>, causes an <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mp ids='MP_0001856'>myocarditis</z:mp> and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The current therapeutic agents for this disease are not always effective and often have severe side effects </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="3962">Curcumin</z:chebi>, a plant <z:chebi fb="0" ids="26195">polyphenol</z:chebi>, has demonstrated a wide range of potential therapeutic effects </plain></SENT>
<SENT sid="3" pm="."><plain>In this study, we examined the effect of <z:chebi fb="0" ids="3962">curcumin</z:chebi> on T. cruzi <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> in vitro and in vivo </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="3962">Curcumin</z:chebi> pretreatment of fibroblasts inhibited parasite invasion </plain></SENT>
<SENT sid="5" pm="."><plain>Treatment reduced the expression of the <z:chebi fb="2" ids="39026">low density lipoprotein</z:chebi> receptor, which is involved in T. cruzi host cell invasion </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="0" ids="3962">Curcumin</z:chebi> treatment of T. cruzi-infected CD1 mice reduced <z:e sem="disease" ids="C0242723" disease_type="Disease or Syndrome" abbrv="">parasitemia</z:e> and decreased the parasitism of infected heart tissue </plain></SENT>
<SENT sid="7" pm="."><plain>This was associated with a significant reduction in macrophage infiltration and <z:mp ids='MP_0001845'>inflammation</z:mp> in both the heart and liver; moreover, <z:chebi fb="0" ids="3962">curcumin</z:chebi>-treated infected mice displayed a 100% survival rate in contrast to the 60% survival rate commonly observed in untreated infected mice </plain></SENT>
<SENT sid="8" pm="."><plain>These data are consistent with <z:chebi fb="0" ids="3962">curcumin</z:chebi> modulating <z:e sem="disease" ids="C0858744" disease_type="Disease or Syndrome" abbrv="">infection-induced</z:e> changes in signaling pathways involved in <z:mp ids='MP_0001845'>inflammation</z:mp>, <z:mp ids='MP_0003674'>oxidative stress</z:mp>, and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain>These data suggest that <z:chebi fb="0" ids="3962">curcumin</z:chebi> and its derivatives could be a suitable drug for the amelioration of chagasic <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e> </plain></SENT>
</text></document>